2,8-Tetradecadien-7-ol, 2,6,9-trimethyl-, (6R,7S,8E)-rel- (485843-66-1)

Identification
Name:	2,8-Tetradecadien-7-ol, 2,6,9-trimethyl-, (6R,7S,8E)-rel-
CAS:	485843-66-1
Molecular Formula:	C₁₇H₃₂O
Molecular Structure:
Properties
Safety Data

Other Product

2,8-Tetradecadien-7-ol, 2,6,9-trimethyl-, (6R,7R,8E)-rel-
8,12-Tetradecadien-3-ol, 5,9,13-trimethyl-2-nitro-, (8E)-
8,12-Tetradecadien-3-ol, 5,9,13-trimethyl-2-nitro-, acetate (ester), (8E)-
4,12-Tetradecadien-9-yn-6-ol,8-methyl-1-[(tetrahydro-2H-pyran-2-yl)oxy]-
4,8-Pentadecadienoicacid, 2-methoxy-3,7-dimethyl-6-(phenylmethoxy)-, methyl ester,(2R,3S,4E,6R,7S,8E)-rel-
1,4-Dioxaspiro[4.4]nonane,7-ethynyl-6-methyl-6-(4-methyl-2-phenyl-2,3-decadien-9-ynyl)-,(6R,7S)-rel-
4,5-Tetradecadien-2-ol
8-Decen-5-one,7-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-3-hydroxy-2-methyl-,(3R,7S,8E)-rel-
2,4,6,8,10-Hexadecapentaenoic acid,13,15-dihydroxy-4,6,10-trimethyl-,(6S,7S,9E,12R)-12-[(1S,3E,5R,6R,8R)-6,8-dihydroxy-1,3,5-trimethyl-3-nonenyl]-7,9-dimethyl-2-oxooxacyclododec-9-en-6-yl ester,(2E,6E,8E,10E,13R,15S)-
2,4,6,8,10-Hexadecapentaenoic acid,13,15-dihydroxy-4,6,10-trimethyl-,(6S,7S,9E,12R)-12-[(1S,3E,5R,6R,8R)-6,8-dihydroxy-1,3,5-trimethyl-3-nonenyl]-7,9-dimethyl-2-oxooxacyclododec-9-en-6-yl ester,(2E,6E,8E,10E,13S,15R)-
2,4,6,8,10-Hexadecapentaenoic acid,13,15-dihydroxy-4,6,10-trimethyl-,(6S,7S,9E,12R)-12-[(1S,3E,5R,6R,8R)-6,8-dihydroxy-1,3,5-trimethyl-3-nonenyl]-7,9-dimethyl-2-oxooxacyclododec-9-en-6-yl ester,(2E,6E,8E,10E,13R,15R)-
2,4,6,8,10-Hexadecapentaenoic acid,13,15-dihydroxy-4,6,10-trimethyl-,(6S,7S,9E,12R)-12-[(1S,3E,5R,6R,8R)-6,8-dihydroxy-1,3,5-trimethyl-3-nonenyl]-7,9-dimethyl-2-oxooxacyclododec-9-en-6-yl ester,(2E,6E,8E,10E,13S,15S)-
2,4,6,8,10-Hexadecapentaenoic acid,12,13,15-trihydroxy-4,6,10-trimethyl-,(6S,7S,9E,12R)-12-[(1S,3E,5R,6R,8R)-6,8-dihydroxy-1,3,5-trimethyl-3-nonenyl]-7,9-dimethyl-2-oxooxacyclododec-9-en-6-yl ester,(2E,4Z,6E,8E,10E,12S,13S,15S)-
2,4,6,8,10-Hexadecapentaenoic acid,12,13,15-trihydroxy-4,6,10-trimethyl-,(6S,7S,9E,12R)-12-[(1S,3E,5R,6R,8R)-6,8-dihydroxy-1,3,5-trimethyl-3-nonenyl]-7,9-dimethyl-2-oxooxacyclododec-9-en-6-yl ester,(2E,4E,6E,8E,10E,12S,13S,15S)-
13-Oxabicyclo[10.1.0]tridec-8-en-6-one,4,12-dimethyl-7-(1-methylethenyl)-9-(1-methylethyl)-,(1R,4S,7S,8E,12R)-rel-(+)- (9CI)
11,13-Tetradecadien-3-ol,2-amino-, (2R,3S,11E)-rel-(+)-
2,7-Tetradecadien-4-ol,6-methyl-5-(phenylmethoxy)-, (2E,4R,5R,6R,7E)-rel-
2,4,6,8,10-Hexadecapentaenoic acid,12,13,15-trihydroxy-2,4,6,10-tetramethyl-,(6S,7S,9E,12R)-12-[(1S,3E,5R,6R,8R)-6,8-dihydroxy-1,3,5-trimethyl-3-nonenyl]-7,9-dimethyl-2-oxooxacyclododec-9-en-6-yl ester,(2E,4E,6E,8E,10E,12S,13S,15S)-
2-Oxabicyclo[4.2.1]non-4-en-3-one,8-(1,3-benzodioxol-5-yl)-9-hydroxy-1,4-dimethoxy-7-methyl-6-(2-propen-1-yl)-,(1R,6R,7S,8R,9S)-rel-
6-Tetradecanol, 7-ethenyl-, (6R,7S)-rel-